DNA Link Inc Cash Flow-to-Debt Ratio
DNA Link Inc cash flow-to-debt ratio. DNA Link Inc (127120) has a Cash Flow-to-Debt Ratio of -0.10x as of March 2026, meaning its operating cash flow of ₩-5.37 Billion could theoretically repay 0% of its total liabilities (₩53.95 Billion) in one year. Check DNA Link Inc (127120) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of DNA Link Inc (2011–2025)
Cash flow-to-debt ratio of DNA Link Inc from 2011 to 2025. Historical debt coverage capacity for DNA Link Inc across 14 annual periods. Check DNA Link Inc (127120) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
DNA Link Inc Cash Flow-to-Debt Ratio by Year (2011–2025)
DNA Link Inc cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for DNA Link Inc. For the full cash flow conversion analysis, see DNA Link Inc (127120) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.17x | ₩-9.39 Billion | ₩54.44 Billion | ▲ +25.4% |
| 2024 | -0.23x | ₩-6.78 Billion | ₩29.36 Billion | ▲ +42.7% |
| 2023 | -0.40x | ₩-5.03 Billion | ₩12.48 Billion | ▼ -791.4% |
| 2022 | 0.06x | ₩910.27 Million | ₩15.62 Billion | ▲ +107.5% |
| 2021 | -0.78x | ₩-6.43 Billion | ₩8.25 Billion | ▼ -1370.3% |
| 2020 | 0.06x | ₩849.38 Million | ₩13.84 Billion | ▲ +176.7% |
| 2019 | -0.08x | ₩-1.30 Billion | ₩16.24 Billion | ▲ +22.8% |
| 2018 | -0.10x | ₩-1.60 Billion | ₩15.46 Billion | ▲ +94.1% |
| 2017 | -1.77x | ₩-2.49 Billion | ₩1.41 Billion | ▼ -1026.6% |
| 2016 | -0.16x | ₩-3.77 Billion | ₩24.04 Billion | ▲ +9.5% |
| 2015 | -0.17x | ₩-3.73 Billion | ₩21.53 Billion | ▼ -1442.2% |
| 2014 | -0.01x | ₩-143.14 Million | ₩12.74 Billion | ▲ +82.3% |
| 2012 | -0.06x | ₩-783.00 Million | ₩12.33 Billion | ▲ +76.7% |
| 2011 | -0.27x | ₩-2.44 Billion | ₩8.97 Billion | — |